Does COVID-19 vaccine have similar immune response in old and young? Here’s what Moderna’s trials show

The drug developer is one of the leading U.S. contenders in the race to develop a safe and effective vaccine against the novel coronavirus and its candidate, mRNA-1273, is already in the Phase 3 stage of human testing.